Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
American Journal of Perinatology|January 7, 2023
Sex-Dependent Differences in Mouse Placental Gene Expression following a Maternal High-Fat DietMatthew R Grace, Neeta L Vora, Lisa Smeester, et al.
Annals of Medicine|February 11, 2023
Ipatasertib, an oral AKT inhibitor, in combination with carboplatin exhibits anti-proliferative effects in uterine serous carcinomaWesley C Burkett, Ziyi Zhao, Meredith A Newton, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|July 7, 2018
Targeted Multiplex Gene Expression Profiling to Measure High-Fat Diet and Metformin Effects on Fetal Gene Expression in a Mouse ModelNeeta L Vora, Matthew R Grace, Lisa Smeester, et al.
Gynecologic Oncology|May 19, 2009
Multicenter analysis of recurrence and survival in stage IIIA endometrial cancerLaura J Havrilesky, Angeles Alvarez Secord, David M O'Malley, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Sedentary Behavior Reduction: A Stepwise Approach to Increasing Physical Activity and Reducing Cardiovascular Disease Risk in Endometrial Cancer SurvivorsLauren C Bates, Margaret I Damare, Erik D Hanson, et al.
Gynecologic Oncology|November 3, 2015
Body mass index and mortality in endometrial cancer: A systematic review and meta-analysisAngeles Alvarez Secord, Vic Hasselblad, Vivian E Von Gruenigen, et al.
Cancer|September 29, 2004
Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?David M Boruta, Paola A Gehrig, Pamela A Groben, et al.
Gynecologic Oncology|December 11, 2025
Associations between obesity and outcomes in pembrolizumab-treated endometrial cancerBryanna Patterson, Nikita Sinha, Emily Broaddus, et al.
Frontiers in Pharmacology|April 1, 2025
Onvansertib exhibits anti-proliferative and anti-invasive effects in endometrial cancerNikita Sinha, Xiaochang Shen, Jennifer Haag, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2009
Attitudes regarding the use of hematopoietic colony-stimulating factors and maintenance of relative dose intensity among gynecologic oncologistsAngeles Alvarez Secord, Victoria Bae-Jump, Laura J Havrilesky, et al.
Pageof 8